Implication of sestrin3 in epilepsy and its comorbidities

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Epilepsy affects 1% of the global population, stemming from acquired brain injury or genetic factors.
• Previous research identified a conserved, pro-epileptic gene network regulated by sestrin3 (SESN3), involving inflammatory processes.
• The precise role of SESN3 in epilepsy pathogenesis and its comorbidities remains largely unexplored.

Purpose of the Study:

• To investigate the role of sestrin3 (SESN3) in seizure susceptibility and epilepsy development.
• To examine the impact of SESN3 deficiency on common epilepsy comorbidities, including anxiety, depression, and cognitive impairment.

Main Methods:

• Phenotypic analysis of SESN3 knock-out rats compared to control rats.
• Assessment of seizure susceptibility, focusing on the onset of status epilepticus.
• Behavioral testing to evaluate anxiety-like behaviors in SESN3 knock-out rats.

Main Results:

• SESN3 knock-out rats exhibited a significant delay in the onset of status epilepticus compared to control rats.
• This finding supports the hypothesis that SESN3 promotes seizure occurrence and/or severity.
• SESN3 knock-out rats displayed reduced anxiety-like behaviors in behavioral tests.

Conclusions:

• Sestrin3 (SESN3) appears to be a key regulator in the mechanisms underlying epilepsy pathogenesis.
• SESN3 deficiency confers a degree of protection against seizures and reduces anxiety.
• These findings suggest SESN3 as a potential therapeutic target for epilepsy and its associated comorbidities.